MedTrace Logo

Pharmacokinetics and Pharmacodynamics of Sertraline After Low Dose Administration

NCT00969852 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2011-01-11

No results posted yet for this study

Summary

This study aimed to explore the pharmacokinetics and pharmacodynamics of low dose sertraline with \[11C\] sertraline positron emission tomography (PET) study.

Conditions

  • Healthy

Interventions

DRUG

Sertraline

Multiple doses of 5, 25, and 50 mg Sertraline for 6 days each period.

Sponsors & Collaborators

  • Ministry of Health, Welfare and Family Affairs

    collaborator UNKNOWN

  • Korea National Enterprise for Clinical Trials

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Kyung-Sang Yu, MD, PhD · Seoul National University College of Medicine and Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2009-08-31
Completion
2010-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00969852 on ClinicalTrials.gov